The largest database of trusted experimental protocols

8 protocols using α1 2 fucosidase

1

Enzymatic Deglycosylation of Glycolipids

Check if the same lab product or an alternative is used in the 5 most similar protocols
NGLs or glycolipids (2 nmol) were dissolved in 70 μl of 50 mm sodium citrate buffer, pH 6.0, containing 0.1 mg/ml bovine serum albumin (BSA) and 0.5 mg/ml sodium cholate. After a brief sonication, 200 units of α1–2 fucosidase (New England Biolabs) were added, and the mixture was incubated at 37 °C for 48 h. The reaction mixture was purified by a C18 cartridge, and the products were eluted with CHCl3/MeOH/H2O, 30:70:30.
+ Open protocol
+ Expand
2

Glycan Analysis of Pluripotent Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Anti-TRA-1-60 (clone TRA-1-60, mouse IgM) was obtained from R&D Systems Inc. (Minneapolis, MN, USA). Horseradish peroxidase (HRP)-conjugated rabbit anti-mouse Ig was obtained from Agilent Technology (Santa Clara, CA, USA). Polyclonal goat anti-podocalyxin IgG and HRP-conjugated rabbit anti-goat IgG secondary antibodies were obtained from R&D Systems. Anti-human iPSC/ESC, R-10G (mouse IgG1), and R-17F (mouse IgG1) antibodies were prepared as described previously [6 (link),8 (link)].
Peptide N-glycanase (PNGase F; recombinant protein from Escherichia coli) was obtained from Roche Diagnostics GmbH (Mannheim, Germany), neuraminidase (Arthrobacter ureafaciens) from Nacalai Tesque (Kyoto, Japan), α1-3/4 fucosidase from TaKaRa Bio, Inc. (Shiga, Japan), and α1-2 fucosidase from New England Biolabs (Ipswich, MA, USA). Chondroitinase ABC (Proteus vulgaris), heparinase mixture (heparinase, heparitinase I, and heparitinase II), keratanase (Pseudomonas sp.), keratanase II (Bacillus sp.), and endo-β-galactosidase (Escherichia freundii) were obtained from Seikagaku Biobusiness (Tokyo, Japan).
+ Open protocol
+ Expand
3

Glycosidase Digestion of Microarrays

Check if the same lab product or an alternative is used in the 5 most similar protocols
For on-array glycosidase digestion, the array was hydrated with HEPES-buffered saline (HBS, 5 mm HEPES, pH 7.4, 150 mm NaCl, 5 mm CaCl2) for 2 min and blocked with 3% bovine serum albumin (BSA, Sigma) in HBS buffer for 1 h before addition of α1,2-fucosidase (New England Biolabs, Hitchin, UK, P0724L Lot 0111505) in 50 mm sodium citrate buffer, supplemented with 100 mm NaCl and 1 μg/ml BSA (pH 6.0). The enzyme was evaluated at 8–20 unit/μl and incubation was at 37 °C for 12–44 h. The binding analyses were performed after treatment with the enzyme at 8–20 unit/μl. The array was then washed 3 times with HBS and once with water and dried at ambient.
+ Open protocol
+ Expand
4

SHBG Purification and Glycan Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
SHBG purified from human serum was purchased from Lee Biosolutions (Maryland Heights, MO). Dithiothreitol (DTT) and all of the solvents of LC–MS grade were obtained from ThermoFisher Scientific (Waltham, MA). Iodoacetamide (IAA) was from MP Biomedicals (Santa Ana, CA). Trypsin Gold (V5280) and ProteaseMax (V2071) were from Promega (Madison, WI). Rapigest SF was from Waters (Milford, MA). α-2–3,6,8,9 Neuraminidase A (P0722), α-2–3 neuraminidase (P0743), α-1–2 fucosidase (P0724), α-1–3,4 fucosidase (P0769), and digestion buffers were from New England Biolabs (Ipswitch, MA). All other chemicals were obtained from Sigma-Aldrich (Saint Louis, MO).
+ Open protocol
+ Expand
5

Enzymatic Labeling for Serum Peak Confirmation

Check if the same lab product or an alternative is used in the 5 most similar protocols
To confirm the identity of individual peaks in the serum, 2AB-labelled samples were either treated with α2-3-neuraminidase (New England Biolabs, #P0743L) or α1-2-fucosidase (New England Biolabs, #P0724S) according to the manufacturer’s instructions. Enzyme-treated and untreated samples were run in parallel and analyzed by HPLC with fluorescence detection, as described above.
+ Open protocol
+ Expand
6

Enzyme-based Glycan Identification

Check if the same lab product or an alternative is used in the 5 most similar protocols
To confirm the identity of individual peaks in AF, 2AB-labelled samples were treated either with α2-3 neuraminidase (New England Biolabs, #P0743L), α2-3,6,8 neuraminidase (New England Biolabs #P0720S) or α1-2-fucosidase (New England Biolabs, #P0724S) according to the manufacturer’s instructions. Enzyme-treated and untreated samples were run in parallel and analyzed by HPLC with fluorescence detection as described above.
+ Open protocol
+ Expand
7

Enzymatic Fucose Removal Optimization

Check if the same lab product or an alternative is used in the 5 most similar protocols
Enzymatic removal of fucose residues was conducted according to the supplier’s protocol (α1-3,4 Fucosidase, α1-2 Fucosidase, New England Biolabs) with minor modifications. Briefly, 20 μg of protein sample was used for the enzymatic treatment by adding 2 μl of the exoglycosidase. The resulting mixture was incubated at 37°C overnight for the removal of the fucose residues, followed by analyzing with SDS–PAGE and immunoblotting analysis.
+ Open protocol
+ Expand
8

Glycan Modification Analysis in BMDCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
The 500 µg of total proteins extracted from wild-type or wls-null (wlsfx/fx) BMDC were added to a 30 k centrifugal filter unit (Merck Millipore, MRCF0R030). Then, urea solution (8 M; Sigma-Aldrich, U5378) was added so as to bring the total volume to 400 µl. Samples were centrifuged at 16,000 x g for 15 min to remove cytosolic contaminants, and 200 µl of urea solution was added to wash it twice. Next, after adding 200 µl of ammonium bicarbonate (50 mM; Sigma-Aldrich, 09830), the tubes were centrifuged at 16,000 x g for 15 min to exchange buffer. The different glycan modifications were released from the samples by the addition of 6 UN of PNGase F (P0704S), O-glycosidase (P0733S), α1-6 mannosidase (P0727S), α2-3,6,8 neuraminidase (P0720S), or α1-2 fucosidase (P0724S), all from New England Biolabs, in 200 μl of NH4HCO3 solution (25 mM) at 37°C; they were digested overnight (16 h) under shaking conditions and finally centrifuged at 16,000 x g for 15 min to get the released glycans in a new tube.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!